REGN trade ideas
Regeneron rejecting new highs? Nice bearish engulfing pattern formed on REGN today, confirming the resistance level above the last bearish engulfing pattern in January 2020.
Bot near Friday Close A bit risky. Seems to have supported by 50% Fib and the gap. Potential catalyst of corona.
$REGN 12-1 AnalysisHard move up after reclaiming 200DMA(red). Being held up steadily by the 9DMA(green). Very overbought and gap has been filled from most recent dramatic drop in April. Look for consolidation around 9/13 soon before moves further up. No confirmation yet of slowdown though. On watch.
$REGN Buy signal in Regeneron PharmaEntry level $345 = Target price $375 = Stop loss $336
Bullish reversal occurring in regenerson after quite a sustained correction.
Historical buy signal is complete on the weekly chart, the daily chart is a little overbought so we await a break in the weekly RSI for a safer entry.
Average analysts price target $383 | Overweight.
P/E ratio 18.78.
Company profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Above 273 can go higher (high risk) So far monthly look like correction. If true, still plenty of chances to get in.
REGN - Potential Long TradeMTHLY: Developing MACD bullish devergence. September XOver @295.87 - October XOver @ 282.03 (below current levels). Potential minor tail formation. Price at suppot level.
WKLY: OBV bullish devergence. IS blue
Daily: IS Blue
Most OBV POCs are above current levels.
If this goes up it could go up pretty solidly.
REGNPossiblle bullish after retracement and buy at 294.55, another bullish after further retracement at resistance.
REGN LONG2 CASES POSSIBLE..as usual UP or DOWN..
Short term Long for REGN .. tgt 325-331
If dumps then we may touch 240 and 215
Currently long at 310. Stop 297.
$REGN Difficult to be bullish on Regeneron Pharma Inc. Regeneron is just another victim of the outflows from healthcare, there is nothing positive to cling to on the chart. As earnings approaches price action can only indicate that more selling is imminent, short for now and look for long on test of support or trend line.
FDA approves Dupixent® (dupilumab) for moderate-to-severe atopicREGN: Regeneron Pharmaceuticals, Inc.
2019-03-11 15:44:00
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents - PR Newswire
$REGN Potential problem potential mini H&S developing on the daily near top of trend line. MACD suggest not enough strength to break TL. Watching for a break of the neckline.
$REGN Short swing Previous channel resistance, i can't help but think this will retest 400 and the 50 ema on daily.
Short REGN (Once 340 confirms a break)Watch very congested area at 340, short it once that is broken.
Short REGN from 365 (Potential bounce)to 183Potential bounce to 365 area before falling again, target price at 183
Really beautiful buying setup - REGNWill wait patiently for REGN to get into the buying box -- expect it to arrive last august
[REGN] phase 1 -> phase 2The price is above 30MM, the slope of 30MM is positive!
If the price breaks the resistant, It will be in phase 2.
But if you take risks, maybe you should buy!
